E
Extrawell Pharmaceutical Holdings Ltd
HKEX:858
Extrawell Pharmaceutical Holdings Ltd
HKEX:858
Price:
0.083
HKD
Market Closed
Market Cap:
HK$211.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
Extrawell Pharmaceutical Holdings Ltd
HKEX:858
|
HK |
|
P
|
Porsche Automobil Holding SE
SWB:PAH3
|
DE |
|
Hot Chili Ltd
ASX:HCH
|
AU |
|
Shenzhen Sunway Communication Co Ltd
SZSE:300136
|
CN |
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
CN |
|
H
|
Hannet Co Ltd
KOSDAQ:052600
|
KR |
|
C
|
China Tower Corp Ltd
OTC:CHWRF
|
CN |
|
H
|
HPP Holdings Bhd
KLSE:HPPHB
|
MY |
Multiples-Based Value
The Multiples-Based Value of one Extrawell Pharmaceutical Holdings Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 0.083 HKD, Extrawell Pharmaceutical Holdings Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Extrawell Pharmaceutical Holdings Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Extrawell Pharmaceutical Holdings Ltd Competitors
Extrawell Pharmaceutical Holdings Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| HK |
E
|
Extrawell Pharmaceutical Holdings Ltd
HKEX:858
|
211.7m HKD | 4 | -0.6 | -22.4 | -22.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
900.7B USD | 13.8 | 43.6 | 29.4 | 31.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581B USD | 6.2 | 21.7 | 15.1 | 18.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.2 | 11.4 | 12.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
304.8B USD | 4.7 | 16.7 | 10.3 | 12.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF | 5.2 | 20.8 | 12.9 | 16.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.2B USD | 2.5 | 20.1 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.2B USD | 2.5 | 16.9 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
